Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

InMode to Participate in Upcoming Investor Conferences

INMODE Logo

News provided by

InMode Ltd.

30 Oct, 2025, 14:30 IST

Share this article

Share toX

Share this article

Share toX

YOKNEAM, Israel, Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in November:

UBS Global Healthcare Conference

Presenter: Yair Malca, Chief Financial Officer

Format: In-person one-on-one meetings

Location: Palm Beach Gardens, FL

When: Monday, November 10

Jefferies Global Healthcare Conference

Presenter: Moshe Mizrahy, Chief Executive Officer

Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst, and one-on-one meetings

Location: London, U.K.

When: Tuesday, November 18, Fireside Chat at 4:00 pm GMT

A live webcast of the presentation can be accessed here.

Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Presenter: Yair Malca, Chief Financial Officer

Format: In-person one-on-one meetings

Location: New York, NY

When: Thursday, November 20

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
[email protected] 

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

SOURCE InMode Ltd.

Modal title

Also from this source

InMode Announces New Share Repurchase Program

InMode Announces New Share Repurchase Program

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized...

InMode Announces Conclusion of Independent Transaction Committee Review

InMode Announces Conclusion of Independent Transaction Committee Review

InMode Ltd. (Nasdaq: INMD) a leading global provider of innovative medical technologies ("InMode" or the "Company"), today announced that the...

More Releases From This Source

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.